biotech / news / / The Economic Times
J&J has halved the time needed to identify promising new drug candidates.
Johnson & Johnson has halved the time needed to identify promising new drug candidates using AI.
KEY POINTS
- AI has reduced the time for preparing clinical trial regulatory reports from 700 hours to 15 minutes.
- J&J is applying AI to optimize manufacturing, such as precisely timing solvent additions.
- AI implementation is expanding, not replacing, existing IT roles at Johnson & Johnson.
COMPANIES
Summarized by Newsio from The Economic Times. How we summarize →